Submit Deal

Submit Deal

Cover Image Phillip Lee

Phillip Lee

Head of Group at SURVEYOR CAPITAL

Investor

Deal Bio

Total Deals7

Valued Deals7

Total Value£ 806 M

Avg. Deal Size£ 115 M

Market Context

Sort

04 Oct 2021|Switzerland|Biotechnology

Target: MOONLAKE IMMUNOTHERAPEUTICS

Bidder: BVF PARTNERS

25 Service Providers

7 Target | 18 Bidder

44 Dealmakers

11 Target | 34 Bidder

£ 169 M

Value

05 Jan 2022|United States|Biotechnology

Target: KORRO BIO

Bidder: ATLAS VENTURE LP

13 Service Providers

2 Target | 11 Bidder

14 Dealmakers

3 Target | 11 Bidder

£ 85 M

Value

25 Jan 2022|United States|Biotechnology

Target: METAGENOMI

Bidder: MODERNA

16 Service Providers

2 Target | 14 Bidder

17 Dealmakers

3 Target | 14 Bidder

£ 129 M

Value

13 Sep 2022|United States|Biotechnology

Target: ACELYRIN

Bidder: WESTLAKE VILLAGE BIOPARTNERS

11 Service Providers

1 Target | 10 Bidder

11 Dealmakers

1 Target | 10 Bidder

£ 257 M

Value

16 May 2023|United States|Biotechnology

Target: BOUNDLESS BIO

Bidder: LEAPS BY BAYER

15 Service Providers

2 Target | 13 Bidder

16 Dealmakers

3 Target | 13 Bidder

£ 80 M

Value

22 May 2023|United States|Biotechnology

Target: QUANTA THERAPEUTICS

Bidder: VIDA VENTURES

11 Service Providers

3 Target | 8 Bidder

11 Dealmakers

3 Target | 8 Bidder

£ 40 M

Value

23 May 2023|United States|Pharmaceuticals

Target: ONKURE THERAPEUTICS

Bidder: SURVEYOR CAPITAL

11 Service Providers

1 Target | 10 Bidder

15 Dealmakers

2 Target | 13 Bidder

£ 43 M

Value

Privacy Policy Terms of Service Contact Us Cookie Preferences

All rights reserved. Copyright © 2025 Datasite